Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The copay coupon scheme is lucrative for pharmaceutical companies, which disburse money to subsidize patient copays as a form of what they characterize as charity
Heres what the clinical evidence shows: Study Scope: 900+ participants across 6 randomized, double-blind, placebo-controlled trials Safety Profile: Indistinguishable from placebo in tolerability assessments Serious Events: Zero serious adverse events attributed to AOD-9604 Withdrawals: No treatment-related discontinuations in any trial Common Effects: Mild headache and minor GI symptoms at rates similar to placebo IGF-1 Impact: No effect on insulin-like growth factor-1 levels Metabolic Safety: No negative impact on glucose metabolism or insulin sensitivity Immunogenicity: Zero participants developed anti-AOD9604 antibodies The following analysis provides complete details on the clinical trial evidence supporting AOD-9604s favorable safety profile
Cell Metab 2022;34:1121-36.ArticlePubMedPMC 50
Anthracycline chemotherapy (doxorubicin, epirubicin) and left-sided radiotherapy can affect cardiac function years after treatment ends
A 14-day intervention study published in Nutrients found that gymnema sylvestre supplementation reduced sugar cravings in adults who self-identified as having a sweet tooth
US$ 27.63
US$ 27.21
US$ 26.22
US$ 20.42
US$ 26.34
